TRAD CHI MED (00570) Reports Annual Net Loss of RMB 458 Million, Swinging from Prior Year's Profit

Stock News
Mar 20

TRAD CHI MED (00570) announced its annual results for the period ending December 31, 2025. The group's revenue was RMB 147.45 billion, a decrease of 10.7% compared to the previous year. The company reported a net loss of RMB 458 million, a swing from profit to loss year-on-year. The basic loss per share was 6.79 cents.

According to the announcement, the loss during the period was primarily due to a decline in revenue scale and profitability in the traditional Chinese medicine formula granules business. This was impacted by factors such as an increased proportion of volume-based procurement business and intensified market competition. Additionally, there was an increase in impairments for goodwill, intangible assets, and credit losses during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10